结论：家族性结肠息肉病是一种遗传性疾病，癌变率较高，早期诊断、合理治疗可以取得满意的疗效。
Conclusions: FPC is a kind of hereditary diseases which has a high cancerization rate; there is satisfactory result when early diagnosis and reasonable treatment are applied.
目的探讨塞莱昔布对家族性结肠息肉病病人术后的肠息肉的防治作用。
Objective To explore the preventive effect of Celecoxib on recurrence of the familial polyposis coli (FPC) after operation.
目的探索外科治疗家族性结肠息肉病的新方法，评价这一新方法的治疗效果。
Objective to explore a new surgical therapy for familial polyposis coli and to evaluate its effective results.
目的探索外科治疗家族性结肠息肉病的新方法，评价这一新方法的治疗效果。
Objective to explore a new surgical therapy for familial polyposis coli and to evaluate its effective results.
应用推荐